Vaccine Sovereignty Without Fragmentation: Building Resilient and Integrated Global Supply Chains

The global race for vaccine sovereignty has reshaped health policy—but without coordination, it risks creating fragmentation instead of resilience. This report delivers a strategic analysis of how BRICS+ can balance national self-reliance with global integration to build efficient, scalable, and equitable vaccine supply chains.

Drawing lessons from the COVID-19 pandemic, the report highlights how over-concentration of production and export restrictions exposed systemic vulnerabilities, prompting countries to localize manufacturing. However, it argues that uncoordinated localization leads to duplication, inefficiencies, regulatory divergence, and weakened global trust. Instead, BRICS+ can lead a model of coordinated interdependence through regional manufacturing hubs, harmonized regulatory standards, and collaborative technology transfer.

The analysis explores key developments in platform technologies, workforce capacity, and global supply chain interlinkages, while emphasizing the importance of maintaining international quality standards and cross-border cooperation. It also outlines scenario-based pathways showing how strategic coordination can enhance resilience, reduce costs, and expand access to vaccines worldwide.

If you are not tracking how vaccine sovereignty is evolving beyond isolation, you are missing a critical shift in global health governance. Follow Global Eye Intelligence for expert insights on BRICS+, vaccine strategy, global health security, pharmaceutical supply chains, regulatory frameworks, and emerging market innovation.